| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |